Guardant Health
GH
#1571
Rank
โ‚น1.196 T
Marketcap
โ‚น9,212
Share price
0.68%
Change (1 day)
210.77%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚น1.196 Trillion

As of December 2025 Guardant Health has a market cap of โ‚น1.196 Trillion. This makes Guardant Health the world's 1571th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.196 T270.82%
2024โ‚น322.64 B18.04%
2023โ‚น273.33 B18.55%
2022โ‚น230.56 B-69.53%
2021โ‚น756.79 B-19.69%
2020โ‚น942.29 B80.08%
2019โ‚น523.26 B132.16%
2018โ‚น225.39 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Guardant Health was reported to be:

โ‚น1.161 Trillion
by Nasdaq info icon info icon
โ‚น1.196 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Natera
NTRA
โ‚น2.919 T 144.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น134.53 B-88.76%๐Ÿ‡บ๐Ÿ‡ธ USA